Page 138 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 138
Cirrhosis and its Complications: Pathophysiology (Cont.)
P0094 IMPAIRED 11B-HYDROXYSTEROID DEHYDROGENASE TYPE
2 ACTIVITY CONTRIBUTES TO RENAL SODIUM AVIDITY IN
HUMAN CIRRHOSIS
Annette Dam Fialla*, Helle C. Thiesson, Peter Bie, Peter H. Hovind, Ove
B. Schaffalitzky de Muckadell, Aleksander Krag, Denmark
P0095 ER STRESS ENHANCES LIVER FIBROSIS THROUGH MIR-
150 DEGRADATION AND XBP-1 SPLICING
Femke Heindryckx*, Francois Binet, Johan Kreuger, Pär Gerwins, Sweden
P0096 D-DIMER AND FIBRINOLYTIC ACTIVITY IN PATIENTS WITH
DECOMPENSATED LIVER CIRRHOSIS
Roberto G. Romanelli*, Annapaola Cellai, Donatella Lami, Cristina Tosti-
Guerra, Rosanna Abbate, Domenico Prisco, Giacomo Laffi, Italy
P0097 PRECISELY QUANTITATING THE DYNAMICS OF LIVER
CIRRHOSIS IN A RAT MODEL
Yan Wang*, Hailin Liu, Xiaoli Huang, Chuwen Lin, China
P0098 MACROPHAGE INHIBITORY CYTOKINE-1 (MIC-1) IS
ASSOCIATED WITH DEGREE OF LIVER FIBROSIS IN HCV-
ePOSTERS RELATED LIVER DISEASE – THE MILC STUDY
Belinda Watson, Alicia Baxter, Vicki Flood, Lynne Schofield,
Hong Ping Zhang, Michelle Lee-Ng, Dianne How-Chow, Sam N. Breit,
David A. Brown, Mark Danta*, Australia
P0099 CHOLESTATIC LIVER FIBROSIS CORRELATES WITH
INCREASED IL-17 AND TGFB-2 EXPRESSION
Miriam Bueno-Topete*, Sara Zepeda-Morales, Leonel García-Benavides,
Susana Del Toro-Arreola, Estela Bastidas-Ramírez, Mary Fafutis-Morris,
Mexico
P0100 QT ADAPTATION DURING EXERCISE IN LIVER CIRRHOSIS:
ADJUNCTIVE SIGNS OF CIRRHOTIC CARDIOMYOPATHY
Roberto G. Romanelli*, Giuseppe Barletta, Riccarda Del Bene,
Fabio Marra, Francesco Venditti, Giacomo Laffi, Italy
TOP 10% SPECTRUM AND SHORT TERM OUTCOME OF RENAL
YI P0101 IMPAIRMENT IN CIRRHOSIS
Shah Vinit*, Ashish Kumar, Praveen Sharma, Rinkesh K. Bansal,
Pankaj Tyagi, Naresh Bansal, Vikas Singla, Mandhir Kumar,
Piyush Ranjan, Munish K. Sachdeva, Anil Arora, India
138 The International Liver Congress™ 2015 • ILC Programme
P0094 IMPAIRED 11B-HYDROXYSTEROID DEHYDROGENASE TYPE
2 ACTIVITY CONTRIBUTES TO RENAL SODIUM AVIDITY IN
HUMAN CIRRHOSIS
Annette Dam Fialla*, Helle C. Thiesson, Peter Bie, Peter H. Hovind, Ove
B. Schaffalitzky de Muckadell, Aleksander Krag, Denmark
P0095 ER STRESS ENHANCES LIVER FIBROSIS THROUGH MIR-
150 DEGRADATION AND XBP-1 SPLICING
Femke Heindryckx*, Francois Binet, Johan Kreuger, Pär Gerwins, Sweden
P0096 D-DIMER AND FIBRINOLYTIC ACTIVITY IN PATIENTS WITH
DECOMPENSATED LIVER CIRRHOSIS
Roberto G. Romanelli*, Annapaola Cellai, Donatella Lami, Cristina Tosti-
Guerra, Rosanna Abbate, Domenico Prisco, Giacomo Laffi, Italy
P0097 PRECISELY QUANTITATING THE DYNAMICS OF LIVER
CIRRHOSIS IN A RAT MODEL
Yan Wang*, Hailin Liu, Xiaoli Huang, Chuwen Lin, China
P0098 MACROPHAGE INHIBITORY CYTOKINE-1 (MIC-1) IS
ASSOCIATED WITH DEGREE OF LIVER FIBROSIS IN HCV-
ePOSTERS RELATED LIVER DISEASE – THE MILC STUDY
Belinda Watson, Alicia Baxter, Vicki Flood, Lynne Schofield,
Hong Ping Zhang, Michelle Lee-Ng, Dianne How-Chow, Sam N. Breit,
David A. Brown, Mark Danta*, Australia
P0099 CHOLESTATIC LIVER FIBROSIS CORRELATES WITH
INCREASED IL-17 AND TGFB-2 EXPRESSION
Miriam Bueno-Topete*, Sara Zepeda-Morales, Leonel García-Benavides,
Susana Del Toro-Arreola, Estela Bastidas-Ramírez, Mary Fafutis-Morris,
Mexico
P0100 QT ADAPTATION DURING EXERCISE IN LIVER CIRRHOSIS:
ADJUNCTIVE SIGNS OF CIRRHOTIC CARDIOMYOPATHY
Roberto G. Romanelli*, Giuseppe Barletta, Riccarda Del Bene,
Fabio Marra, Francesco Venditti, Giacomo Laffi, Italy
TOP 10% SPECTRUM AND SHORT TERM OUTCOME OF RENAL
YI P0101 IMPAIRMENT IN CIRRHOSIS
Shah Vinit*, Ashish Kumar, Praveen Sharma, Rinkesh K. Bansal,
Pankaj Tyagi, Naresh Bansal, Vikas Singla, Mandhir Kumar,
Piyush Ranjan, Munish K. Sachdeva, Anil Arora, India
138 The International Liver Congress™ 2015 • ILC Programme
